Synthetic PreImplantation Factor ( DrugBank: Preimplantation factor, Synthetic PreImplantation Factor )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
95	Autoimmune hepatitis	2

95. Autoimmune hepatitis

---

Clinical trials : 52 /  Drugs : 68 - (DrugBank : 27) / Drug target genes : 18 - Drug target pathways : 111

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03593460 (ClinicalTrials.gov)	January 1, 2019	7/6/2018	Phase II AutoImmune Hepatitis	Phase II, Open Label, Adaptive Design, Multiple Dose Finding Study to Investigate Synthetic PreImplantation Factor (sPIF) in Patients With Autoimmune Hepatitis (AIH)	Hepatitis, Autoimmune	Drug: Synthetic PreImplantation Factor	Christopher O'Brien, MD	BioIncept LLC	Withdrawn	18 Years	75 Years	All	0	Phase 2	NULL
2	NCT02239562 (ClinicalTrials.gov)	November 14, 2014	10/9/2014	sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS	A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of Synthetic PreImplantation Factor (sPIF) in Autoimmune Hepatitis	Autoimmune Hepatitis	Drug: sPIF;Drug: Placebo	Christopher O'Brien, MD	BioIncept LLC	Completed	18 Years	70 Years	Female	36	Phase 1	United States